Joseph Burnett sold $714k of CLPT
CEO and President at ClearPoint Neuro, Inc.. 26,463 shares at an average of $26.98, traded Oct 10, 2025, filed Oct 14, 2025.
Score components
- +25RoleCEO
- +21Trade size$714k at market
- +5Share of holdings soldSold 11% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-239077, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 10, 2025 | SOpen-market sale Common Stockindirect: See Footnote10b5-1 | -17,583 | $26.51 | $466k | 225,939 | Oct 14, 2025 |
| Oct 10, 2025 | SOpen-market sale Common Stockindirect: See Footnote10b5-1 | -6,599 | $27.64 | $182k | 219,340 | Oct 14, 2025 |
| Oct 10, 2025 | SOpen-market sale Common Stockindirect: See Footnote10b5-1 | -1,981 | $28.64 | $57k | 217,359 | Oct 14, 2025 |
| Oct 10, 2025 | SOpen-market sale Common Stockindirect: See Footnote10b5-1 | -300 | $29.21 | $8,763 | 217,059 | Oct 14, 2025 |
Related signals
Other insiders at ClearPoint Neuro, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | ClearPoint Neuro, Inc. | Timothy T. Richards director | $133k 10,000 shares | -11% | |
| 54Moderate | ClearPoint Neuro, Inc. | Joseph Burnett CEO and President | $282k 21,247 shares | -8% | |
| 46Moderate | ClearPoint Neuro, Inc. | Lynnette C Fallon director | $128k 10,200 shares | -20% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.